SCHEMBL6458256

SCHEMBL6458256

CCCCC(CCCC(=O)O)C(=O)OCC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 1/20 0.48
CA2 P00918 2/20 0.47
CA1 P00915 1/20 0.47
MAPK1 P28482 1/20 0.47
GPR84 Q9NQS5 7/20 0.47
PPARG P37231 7/20 0.47
PPARD Q03181 7/20 0.47
PPARA Q07869 7/20 0.47
HDAC11 Q96DB2 5/20 0.47
TSHR P16473 4/20 0.47
PTPN1 P18031 3/20 0.47
ALDH1A1 P00352 2/20 0.47
TLR2 O60603 2/20 0.47
TDP1 Q9NUW8 2/20 0.47
FABP4 P15090 2/20 0.47
FFAR1 O14842 2/20 0.47
FFAR4 Q5NUL3 2/20 0.47
SLC22A6 Q4U2R8 1/20 0.47
SLC22A8 Q8TCC7 1/20 0.47
MEN1 O00255 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dodecanoate SCHEMBL28889306 0.91 FFAR4 (0.59) AKR1B1GPR84PPARGPPARDPPARA
Octanoic Acid SCHEMBL29070665 0.89 FFAR4 (0.61) AKR1B1GPR84PPARGPPARDPPARA
SCHEMBL7717443 0.89 FFAR4 (0.61) AKR1B1GPR84PPARGPPARDPPARA
Stearic Acid SCHEMBL27732488 0.89 FFAR4 (0.61) AKR1B1GPR84PPARGPPARDPPARA
SCHEMBL5491480 0.88 CA2 (0.57) CA2CA1MAPK1TSHRALDH1A1
SCHEMBL6935643 0.87 AKR1B1 (0.47) AKR1B1CA2CA1MAPK1GPR84
SCHEMBL28042973 0.87 ALDH1A1 (0.51) AKR1B1GPR84PPARGPPARDPPARA
SCHEMBL4113412 0.87 CA2 (0.48) AKR1B1CA2CA1MAPK1GPR84
SCHEMBL21052329 0.86 CA2 (0.55) CA2CA1MAPK1TSHRALDH1A1
Hydrochloric Acid SCHEMBL27486062 0.86 CA2 (0.55) CA2CA1MAPK1TSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1513848-A4 METHOD OF TREATING ISCHEMIA REPERFUSION INJURY USING ADENOSINE RECEPTOR ANTAGONISTS BIOGEN IDEC INC (US) 2005-11-09 EP disclosed
EP-1513848-A2 METHOD OF TREATING ISCHEMIA REPERFUSION INJURY USING ADENOSINE RECEPTOR ANTAGONISTS Biogen Idec MA Inc. (US) 2005-03-16 EP disclosed
WO-2003105666-A2 METHOD OF TREATING ISCHEMIA REPERFUSION INJURY USING ADENOSINE RECEPTOR ANTAGONISTS BIOGEN, INC. (US) 2003-12-24 WO disclosed